Similar articles

• Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women.

  Fujita K, Kasayama S, Hashimoto J, Nagasaka Y, Nakano N, Morimoto Y, Barnes PJ, Miyatake A. Fujita K, et al. J Bone Miner Res. 2001 Apr;16(4):782-7. doi: 10.1359/jbmr.2001.16.4.782. J Bone Miner Res. 2001. PMID: 11316007
• Inhaled corticosteroids, bone formation, and osteocalcin.

  Peretz A, Bourdoux PP. Peretz A, et al. Lancet. 1991 Nov 23;338(8778):1340. doi: 10.1016/0140-6736(91)92648-l. Lancet. 1991. PMID: 1682726 Clinical Trial. No abstract available.
• Biochemical markers of bone turnover: an update.

  van Daele PL, Birkenhäger JC, Pols HA. van Daele PL, et al. Neth J Med. 1994 Feb;44(2):65-72. Neth J Med. 1994. PMID: 8208326 Review.
• Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.

  Kaddam IM, Iqbal SJ, Holland S, Wong M, Manning D. Kaddam IM, et al. Ann Clin Biochem. 1994 Jul;31 ( Pt 4):327-30. doi: 10.1177/000456329403100403. Ann Clin Biochem. 1994. PMID: 7979096
• [The significance of bone biochemical markers and its application for clinics].

  Nishijima R, Kamimiya F, Horiuchi T. Nishijima R, et al. Nihon Rinsho. 2004 Feb;62 Suppl 2:333-8. Nihon Rinsho. 2004. PMID: 15035147 Review. Japanese. No abstract available.